Optimal working dilution should be determined by the investigator.
Restrictions
For Research Use only
Format
Liquid
Concentration
1.0 mg/mL
Serafini, Severa, Columba-Cabezas, Rosicarelli, Veroni, Chiappetta, Magliozzi, Reynolds, Coccia, Aloisi: "Epstein-Barr virus latent infection and BAFF expression in B cells in the multiple sclerosis brain: implications for viral persistence and intrathecal B-cell activation." in: Journal of neuropathology and experimental neurology, Vol. 69, Issue 7, pp. 677-93, (2010) (PubMed).
Lung, Tong, Sung, Leung, Ng, Chau, Chan, Ng, Lo, To: "Modulation of LMP2A expression by a newly identified Epstein-Barr virus-encoded microRNA miR-BART22." in: Neoplasia (New York, N.Y.), Vol. 11, Issue 11, pp. 1174-84, (2009) (PubMed).
Target
EBV LMP2A
(Epstein-Barr Virus Latent Membrane Protein 2A (EBV LMP2A))